The government’s recent tweak in levies -- removing customs duty waiver as well as imposing excise duty, on certain life-saving drugs including cancer, HIV, haemophilia, diabetes and infections, may result in price increases between 10-25% on both imported and indigenously-produced drugs, swelling treatment costs and restricting key drugs for patients.
